117 results
Page 5 of 6
424B5
mthaqig885z44
2 Aug 19
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
e7n108wrv7rid 52aah5
1 Aug 19
Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:24pm
8-K
EX-99.1
l4dde2
2 May 19
Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
9n3mrbtum
13 Mar 19
Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
4:12pm
8-K
EX-99.1
fbd7763ly bc4a3mmx5
7 Nov 18
Viking Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B5
opl4ha0y
21 Sep 18
Prospectus supplement for primary offering
4:16pm
8-K
EX-1.1
b1wkr65akxvagy
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
424B5
jwojji
19 Sep 18
Prospectus supplement for primary offering
4:27pm
8-K
EX-99.1
gf0oz19fb kbsos
9 Aug 18
Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
12:00am